COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 1581: Articles 15801-15810  | Next

Latin American Registry of renal involvement in COVID-19 disease. The relevance of assessing proteinuria throughout the clinical course.
Lombardi, R.
10.1101/2021.05.01.21256389 — Posted: 2021-05-04
The Physiologic Response to COVID-19 Vaccination
Quer, G., Gadaleta, M., Radin, J. M., Andersen, K. G., Baca-Motes, K., Ramos, E., Topol, E. J., Steinhubl, S. R.
10.1101/2021.05.03.21256482 — Posted: 2021-05-04
Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis.
Badenoch, J. B., Rengasamy, E. R., Watson, C. J., Jansen, K., Chakraborty, S., Sundaram, R. D., Hafeez, D., Burchill, E., Saini, A., Thomas, L., Cross, B., Hunt, C. K., Conti, I., Ralovska, S., Hussain, Z., Butler, M., Pollak, T. A., Koychev, I., Michael, B. D., Holling, H., Nicholson, T. R., Rogers, J. P., Rooney, A. G., The SARS-CoV-Neuro Collaboration
10.1101/2021.04.30.21256413 — Posted: 2021-05-04
COVID-19 vaccine-associated cerebral venous thrombosis in Germany: a descriptive study
Schulz, J. B., Berlit, P., Diener, H.-C., Gerloff, C., Greinacher, A., Klein, C., Petzold, G., Poli, S., Piccininni, M., Kurth, T., Roehrig, R., Steinmetz, H., Thiele, T.
10.1101/2021.04.30.21256383 — Posted: 2021-05-04
COVID-19 and acute kidney injury in German hospitals 2020
Walendy, V., Girndt, M., Greinert, D.
10.1101/2021.04.30.21256331 — Posted: 2021-05-04
The method utilized to purify the SARS-CoV-2 N protein can affect its molecular properties
Tarczewska, A., Kolonko-Adamska, M., Zarebski, M., Dobrucki, J. W., Ozyhar, A., Greb-Markiewicz, B.
10.1101/2021.05.03.442392 — Posted: 2021-05-04
Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant
Nyayanit, D. A., Sarkale, P., Shete-Aich, A., Kumar, A., Patil, S., Majumdar, T., Baradkar, S., Gawande, P., Mohandas, S., Yadav, P. D.
10.1101/2021.04.30.442222 — Posted: 2021-05-04
The Immunological Factors Predisposing To Severe COVID-19 Are Already Present In Healthy Elderly And Men
Kilic, G., Bulut, O., Jaeger, M., ter Horst, R., Koeken, V., Moorlag, S. J. C. F. M., Mourits, V., de Bree, C., Dominguez-Andres, J., Joosten, L. A. B., Netea, M.
10.1101/2021.04.30.442229 — Posted: 2021-05-04
Vitamin C inhibits SARS coronavirus-2 main protease essential for viral replication
Malla, T. N., Pandey, S., Poudyal, I., Aldama, L., Feliz, D., Noda, M., Phillips, G. N., Stojkovic, E. A., Schmidt, M.
10.1101/2021.05.02.442358 — Posted: 2021-05-03
ACE2 expression in rat brain: implications for COVID-19 associated neurological manifestations
Hernandez, V. S., Zetter, M. A., Guerra, E. C., Hernandez-Araiza, I., Karuzin, N., Hernandez-Perez, O. R., Eiden, L. E., Zhang, L.
10.1101/2021.05.01.442293 — Posted: 2021-05-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).